INNOTERE Biomaterial Overview
- Year Founded
-
2004
- Status
-
Acquired/Merged
- Employees
-
8
- Latest Deal Type
-
M&A
INNOTERE Biomaterial General Information
Description
Developer of tissue engineering and regeneration materials intended for the treatment of bone and improved implant fixation in osteoporotic bone. The company researches and manufactures innovative bone cement based on calcium phosphates and methyl methacrylate, enabling medical practitioners to treat patients with damaged bones and tissues through minimally invasive surgery.
Contact Information
Website
www.innotere.de(Operating Subsidiary)
Corporate Office
- Pharmapark Radebeul
- Meissner Strasse 191
- 01445 Radebeul
- Germany
Corporate Office
- Pharmapark Radebeul
- Meissner Strasse 191
- 01445 Radebeul
- Germany
INNOTERE Biomaterial Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Merger/Acquisition | 21-Oct-2025 | Completed | Generating Revenue | |||
| 1. Later Stage VC (Series B) | 01-Mar-2020 | Completed | Generating Revenue |
INNOTERE Biomaterial Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
INNOTERE Biomaterial Patents
INNOTERE Biomaterial Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20180161477-A1 | Structured mineral bone replacement element | Inactive | 08-Dec-2016 | ||
| EP-3332815-A1 | Structured mineral bone replacement mould | Active | 08-Dec-2016 | ||
| EP-3332815-B1 | Structured mineral bone replacement mould | Active | 08-Dec-2016 | ||
| ES-2837425-T3 | Structured mineral bone substitute mold | Active | 08-Dec-2016 | ||
| DE-102016224453-A1 | Structured mineral bone substitute moldings | Active | 08-Dec-2016 | B33Y80/00 |
INNOTERE Biomaterial Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
INNOTERE Biomaterial Former Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Nivalis Group | Venture Capital | Minority |
INNOTERE Biomaterial FAQs
-
When was INNOTERE Biomaterial founded?
INNOTERE Biomaterial was founded in 2004.
-
Where is INNOTERE Biomaterial headquartered?
INNOTERE Biomaterial is headquartered in Radebeul, Germany.
-
What is the size of INNOTERE Biomaterial?
INNOTERE Biomaterial has 8 total employees.
-
What industry is INNOTERE Biomaterial in?
INNOTERE Biomaterial’s primary industry is Therapeutic Devices.
-
Is INNOTERE Biomaterial a private or public company?
INNOTERE Biomaterial is a Private company.
-
What is INNOTERE Biomaterial’s current revenue?
The current revenue for INNOTERE Biomaterial is .
-
Who are INNOTERE Biomaterial’s investors?
Nivalis Group has invested in INNOTERE Biomaterial.
-
When was INNOTERE Biomaterial acquired?
INNOTERE Biomaterial was acquired on 21-Oct-2025.
-
Who acquired INNOTERE Biomaterial?
INNOTERE Biomaterial was acquired by Heraeus Holding.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
